The study was a cluster randomized clinical trial conducted across 43 US cardiology clinics from July 2019 through May 2022, with a follow-up period through December 2022. The trial enrolled 1049 participants, of which 459 were...
Most Recent Articles
Clopidogrel vs. Aspirin for Long-term Maintenance After PCI: Cardiovascular Outcomes in Patients With and Without Diabetes
The study investigated the efficacy and safety of clopidogrel versus aspirin as long-term maintenance therapy after dual antiplatelet therapy for coronary stenting in patients with and without diabetes. The researchers conducted...
VISUALIZED: FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
Read further: FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
FFRCT Analysis Reveals Significant Benefits of Icosapent Ethyl in Patients with Atherosclerosis and Elevated Triglycerides
The EVAPORATE trial enrolled 80 patients with moderate to high-risk atherosclerosis and persistent elevated triglycerides despite statin therapy. The trial demonstrated that IPE significantly reduced plaque volume and had an...
The Impact of Social Determinants of Health on Cardiovascular Outcomes
This state-of-the-art review highlights the significance of social determinants of health (SDOH) and their impact on cardiovascular health, care, and outcomes. SDOH encompasses various social conditions such as economic...
